Bruker Corp. closed the acquisition of a technology platform and product line to expand its range of bacterial, viral and toxin detection solutions for homeland security bio-detection and for selected microbiology applications.
Financial details were not disclosed.
Acquired assets include intellectual property, a field-portable, electrochemical chip-based detection instrument and associated consumable kits for on-site, fast identification of selected bacteria, viruses and toxins.
The acquired instrument platform, the portable Bio-Detector integrated or pBDi, is ready for immediate commercial launch. The multiplex enzyme-linked immunosorbent assay-based detection with an electrochemical chip readout allows on-site identification of various bio-threats, including toxins, with very high sensitivity.